Brokerages forecast that Liquidia Technologies Inc (NASDAQ:LQDA) will post sales of $690,000.00 for the current quarter, Zacks reports. Two analysts have provided estimates for Liquidia Technologies’ earnings. The highest sales estimate is $770,000.00 and the lowest is $600,000.00. The firm is scheduled to issue its next earnings report on Thursday, August 1st.
On average, analysts expect that Liquidia Technologies will report full-year sales of $2.42 million for the current financial year, with estimates ranging from $1.90 million to $2.93 million. For the next fiscal year, analysts anticipate that the company will post sales of $2.52 million, with estimates ranging from $2.50 million to $2.54 million. Zacks’ sales calculations are an average based on a survey of sell-side analysts that cover Liquidia Technologies.
Liquidia Technologies (NASDAQ:LQDA) last posted its earnings results on Thursday, May 2nd. The company reported ($0.87) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.60) by ($0.27). Liquidia Technologies had a negative return on equity of 222.47% and a negative net margin of 1,964.76%.
A number of research firms recently issued reports on LQDA. Wedbush set a $85.00 target price on Pacira Biosciences and gave the stock a “buy” rating in a research note on Friday, June 28th. Zacks Investment Research cut Haynes International from a “hold” rating to a “sell” rating in a research note on Wednesday, May 8th. One research analyst has rated the stock with a hold rating and four have issued a buy rating to the company’s stock. The stock has a consensus rating of “Buy” and an average price target of $31.80.
A number of large investors have recently added to or reduced their stakes in the business. Marshall Wace LLP acquired a new position in Liquidia Technologies during the 1st quarter worth approximately $32,000. New York State Common Retirement Fund acquired a new position in Liquidia Technologies during the 4th quarter worth approximately $96,000. Northern Trust Corp boosted its position in Liquidia Technologies by 9.5% during the 4th quarter. Northern Trust Corp now owns 56,333 shares of the company’s stock worth $1,221,000 after acquiring an additional 4,864 shares during the last quarter. FMR LLC boosted its position in Liquidia Technologies by 3.2% during the 4th quarter. FMR LLC now owns 253,240 shares of the company’s stock worth $5,485,000 after acquiring an additional 7,938 shares during the last quarter. Finally, BlackRock Inc. boosted its position in Liquidia Technologies by 7.1% during the 4th quarter. BlackRock Inc. now owns 231,400 shares of the company’s stock worth $5,011,000 after acquiring an additional 15,415 shares during the last quarter. 56.37% of the stock is owned by hedge funds and other institutional investors.
NASDAQ LQDA traded up $0.02 during trading hours on Friday, reaching $7.75. 16,956 shares of the company’s stock were exchanged, compared to its average volume of 86,465. The business’s 50-day moving average price is $8.48. Liquidia Technologies has a one year low of $7.21 and a one year high of $38.46. The company has a debt-to-equity ratio of 0.46, a current ratio of 5.57 and a quick ratio of 5.57. The firm has a market capitalization of $144.48 million and a P/E ratio of -1.03.
Liquidia Technologies Company Profile
Liquidia Technologies, Inc, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of human therapeutics. Its lead product candidate, LIQ861, an inhaled dry powder formulation of treprostinil that is in Phase III clinical trials used for the treatment of pulmonary arterial hypertension.
Recommended Story: Do back-end load funds outperform no-load funds?
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Liquidia Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Liquidia Technologies and related companies with MarketBeat.com's FREE daily email newsletter.